Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.04B
Enterprise Value3.94B
P/E Ratio-5.93
PEG Ratio-0.89
Price/Sales Ratio3.72
Price/Book Ratio7.8
Enterprise/Revenue5.31
Enterprise/EBITDA-13.13

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.64
Operating Margin-0.59
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.9

Income Statement

Revenue900.84M
Revenue/Share1.6
Gross Profit264.37M
EBITDA-127.85M
Net Income-287.37M
Diluted EPS-0.72

Balance Sheet

Total Cash38.91M
Total Cash/Share0.1
Total Debt1.05B
Total Debt/Equity3.51
Current Ratio0.51
Book Value Per Share0.87

Price History

52-Week Change-36.39
52-Week High10.37
52-Week Low5.15
Moving Average 50 Days5.88
Moving Average 200 Days6.72

Statistics

Average Volume1.81M
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split FactorN/A
Last Split DateN/A
AD